| 53.73 Delayed Data As of Aug 23 |  -1.31 / -2.38%Today’s Change | 31.97 Today|||52-Week Range 64.48 | +37.95% Year-to-Date |
| Previous close | 55.04 |
| Today’s open | 54.73 |
| Day’s range | 53.46 - 55.94 |
| Volume | 442,966 |
| Average volume (3 months) | 546,864 |
| Market cap | $2.8B |
| Earnings growth (last year) | +76.88% |
| Earnings growth (this year) | +1,434.38% |
| Earnings growth (next 5 years) | -45.30% |
| Revenue growth (last year) | -15.78% |
| P/E ratio | 4.6 |
| Price/Sales | 101.96 |
| Price/Book | 4.54 |
| Today’s change | Today’s % change | |
|---|---|---|
| GBTGlobal Blood Therape... | -1.78 | -3.78% |
| HCMHutchison China Medi... | +0.15 | +0.73% |
| PTCTPTC Therapeutics Inc | -1.49 | -3.30% |
| MDCOMedicines Co | -0.76 | -2.12% |
| Next reporting date | November 6, 2019 |
| EPS forecast (this quarter) | -$1.31 |
| Annual revenue (last year) | $18.0M |
| Annual profit (last year) | -$30.1M |
| Net profit margin | -158.98% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Amit Dilip Munshi |
Chief Financial Officer & Executive Vice President Kevin R. Lind |
Corporate headquarters San Diego, California |
